Objective:To investigate the effects of Comprehensive Geriatric Assessment(CGA)-guided multidisciplinary interventions on frail non-dialysis elderly patients with chronic kidney disease, while also assessing the influence of different levels of frailty.Methods:This study is a randomized controlled trial conducted between 2020 and 2021, involving 230 frail, non-dialysis elderly patients with chronic kidney disease stages 3-5, treated at our hospital.Participants were randomly assigned to either an intervention group or a control group using a random number table method, with 115 patients in each group.The intervention group received multidisciplinary treatment over a period of 12 months, while the control group received standard care.We compared Fried frailty scores, re-hospitalization rates, and all-cause mortality between the two groups, and documented changes in CGA both before treatment and 12 months after treatment.Results:After 12 months of treatment, the Fried frail phenotype score was significantly lower in the intervention group(2.7±1.2)compared to the control group(3.6±1.8, t=97.47, P<0.01).Additionally, grip strength in the intervention group was higher(20.6±8.5 kg)than in the control group(13.5±8.1 kg, t=6.57, P<0.01).The scores for the Mini Nutritional Assessment-Short Form(MNA-SF)(10.7±4.0 vs.9.1±4.2, t=29.03, P<0.01), Mini-Mental State Examination Scale(MMSE)(24.3±8.6 vs.19.3±9.6, t=96.35, P<0.01), and Short Physical Performance Battery(SPPB)(6.8±3.2 vs.3.5±2.9, t=71.97, P<0.01)were also significantly higher in the intervention group.Furthermore, the Activity of Daily Living(ADL)score was greater in the intervention group(5.4±1.6)than in the control group(3.9±1.6, t=5.75, P<0.01), as was weight(67.2±11.2 kg vs.64.0±11.8 kg, t=2.02, P=0.045).The frailty reversal rate was significantly higher in the intervention group(32.2% vs.8.0%, χ2=21.4, P<0.01), and the all-cause mortality rate was lower in this group(11.3% vs.22.6%, χ2=5.22, P=0.022).However, there were no significant differences observed in the Geriatric Depression Scale(GDS)(6.3±3.7 vs.6.0±4.3, t=24.29, P>0.05), estimated Glomerular Filtration Rate(eGFR)[(44.1±19.2)ml·(min·1.73m 2) -1vs.(39.8±19.0)ml·(min·1.73m 2) -1, t=1.76, P>0.05], Instrumental Activity of Daily Living(IADL)(5.2±2.2 vs.4.6±2.2, t=1.49, P>0.05), and the rate of readmission(25.2% vs.36.5%, χ2=3.44, P>0.05). Conclusions:Multidisciplinary interventions derived from a comprehensive geriatric assessment can ameliorate or even reverse frailty, reduce all-cause mortality, and enhance the prognosis of frail elderly patients with chronic kidney disease stages 3 to 5 who are not undergoing dialysis.

Objective:To investigate the effects of Comprehensive Geriatric Assessment(CGA)-guided multidisciplinary interventions on frail non-dialysis elderly patients with chronic kidney disease, while also assessing the influence of different levels of frailty.Methods:This study is a randomized controlled trial conducted between 2020 and 2021, involving 230 frail, non-dialysis elderly patients with chronic kidney disease stages 3-5, treated at our hospital.Participants were randomly assigned to either an intervention group or a control group using a random number table method, with 115 patients in each group.The intervention group received multidisciplinary treatment over a period of 12 months, while the control group received standard care.We compared Fried frailty scores, re-hospitalization rates, and all-cause mortality between the two groups, and documented changes in CGA both before treatment and 12 months after treatment.Results:After 12 months of treatment, the Fried frail phenotype score was significantly lower in the intervention group(2.7±1.2)compared to the control group(3.6±1.8, t=97.47, P<0.01).Additionally, grip strength in the intervention group was higher(20.6±8.5 kg)than in the control group(13.5±8.1 kg, t=6.57, P<0.01).The scores for the Mini Nutritional Assessment-Short Form(MNA-SF)(10.7±4.0 vs.9.1±4.2, t=29.03, P<0.01), Mini-Mental State Examination Scale(MMSE)(24.3±8.6 vs.19.3±9.6, t=96.35, P<0.01), and Short Physical Performance Battery(SPPB)(6.8±3.2 vs.3.5±2.9, t=71.97, P<0.01)were also significantly higher in the intervention group.Furthermore, the Activity of Daily Living(ADL)score was greater in the intervention group(5.4±1.6)than in the control group(3.9±1.6, t=5.75, P<0.01), as was weight(67.2±11.2 kg vs.64.0±11.8 kg, t=2.02, P=0.045).The frailty reversal rate was significantly higher in the intervention group(32.2% vs.8.0%, χ2=21.4, P<0.01), and the all-cause mortality rate was lower in this group(11.3% vs.22.6%, χ2=5.22, P=0.022).However, there were no significant differences observed in the Geriatric Depression Scale(GDS)(6.3±3.7 vs.6.0±4.3, t=24.29, P>0.05), estimated Glomerular Filtration Rate(eGFR)[(44.1±19.2)ml·(min·1.73m 2) -1vs.(39.8±19.0)ml·(min·1.73m 2) -1, t=1.76, P>0.05], Instrumental Activity of Daily Living(IADL)(5.2±2.2 vs.4.6±2.2, t=1.49, P>0.05), and the rate of readmission(25.2% vs.36.5%, χ2=3.44, P>0.05). Conclusions:Multidisciplinary interventions derived from a comprehensive geriatric assessment can ameliorate or even reverse frailty, reduce all-cause mortality, and enhance the prognosis of frail elderly patients with chronic kidney disease stages 3 to 5 who are not undergoing dialysis.

Objective:To explore the correlation between protein energy wasting(PEW)and frailty in elderly patients on maintenance hemodialysis(MHD)and influencing factors of frailty.Methods:Clinical data of patients over 60 who had received regular hemodialysis treatment at Beijing Huairou Hospital between September to December 2021 were collected.According to Fried's evaluation criteria, patients were divided into a frailty group and a non-frailty group, and differences between the two groups were compared.Spearman correlation analysis was conducted to assess the correlation between protein energy wasting and frailty.Logistic regression was used to analyze the influencing factors of frailty in elderly patients on MHD.Results:A total of 81 MHD patients enrolled in this study, with 36 in the frailty group.The frailty group was older, had a higher proportion of patients with PEW, and underwent more months of dialysis, with a higher proportion of patients with diabetic nephropathy as the primary disease, having high levels of C-reactive protein(CRP), and having low KT/V, hemoglobin, albumin, body mass index(BMI), mid-arm circumference(MAC)and mid-arm muscle circumference(MAMC), and the differences with the control group were statistically significant(all P<0.05). The Fried frailty phenotype was positively correlated with age( r=0.021, P=0.047), but negatively associated with HGB( r=-0.329, P=0.003), albumin( r=0.021, P=0.047), BMI( r=0.021, P=0.047), TSF( r=-0.274, P=0.013), MAC( r=-0.554, P<0.001)and MAMC( r=-0.293, P=0.008). A Logistic regression equation was constructed using frailty as the dependent variable.The results showed that age, months of dialysis, KT/V, serum albumin and CRP were independent factors influencing the development of frailty in elderly patients with MHD. Conclusions:PEW and frailty coexist and interact with each other in elderly patients with MHD.Clinicians should place emphasis on the assessment of frailty and protein energy wasting in elderly dialysis patients and achieve early detection and intervention to avoid adverse clinical outcomes.

Objective:To compare the clinicopathological differences between elderly and non-elderly patients with idiopathic membranous nephropathy(IMN).Methods:Patients diagnosed with IMN via renal biopsy at Beijing Huairou Hospital, Beijing Changping Hospital of Traditional Chinese Medicine, and Beijing Hospital of Traditional Chinese Medicine from January 2017 to August 2021 were retrospectively enrolled.They were classified into the elderly group(≥65 years)and the non-elderly group(<65 years), and the clinicopathological differences between the two groups were compared.Results:A total of 207 IMN patients were included in the study, with a male to female ratio of 1.7∶1.0.There were 56 patients in the elderly group, aged(68.2±3.1)years, and 151 patients in the non-elderly group, aged(48.2±6.2)years.Compared with the non-elderly group, the elderly group had a longer time from onset to renal biopsy and a higher proportion of patients with renal insufficiency and hypertension( P<0.05). The elderly group had a lower eGFR, lower serum albumin, higher serum cholesterol, and higher low-density lipoprotein than the non-elderly group( P<0.05). The proportions of patients with glomerulosclerosis, renal tubular atrophy, and interstitial fibrosis in the elderly group were higher than in the non-elderly group( P<0.05). The positive rates of glomerular PLA2R antigen staining in the two groups were 90.6%(29/32)and 91.0%(111/122), respectively, and there was no statistically significant difference between the two groups.IgG4 deposition represented the most common IgG subtype, with 93.8%(30/32)in the elderly group and 94.3%(115/122)in the non-elderly group.There was no statistical significance between the two groups( P>0.05). Conclusions:Compared with non-elderly IMN patients, a higher proportion of elderly IMN patients has renal insufficiency, hypertension and chronic renal pathology.The glomerular deposition of pathogenic antigens in elderly IMN patients was similar to that in non-elderly IMN patients, suggesting no difference in pathogenesis between the two groups.The clinicopathological differences between the two groups may be related to age and complications.

Studies have shown that sarcopenia can result in adverse clinical outcomes, including reduced quality of life and increased hospitalization and mortality rates.Compared with the general population, the prevalence of sarcopenia in patients with chronic kidney disease is significantly higher.This phenomenon is closely related to the complicated pathogenesis of the chronic kidney disease.In this review, we mainly discuss the epidemeology, etiology, pathogenesis and interventions of sarcopenia in patients with chronic kidney disease to provide reference for the treatment and prevention of sarcopenia in patients with chronic kidney disease.

Objective:To investigate the prevalence of frailty in elderly patients with stage 3-5 non-dialysis chronic kidney disease(ND-CKD)and to analyze its related factors.Methods:A cross-sectional study was conducted.Patients ≥65 years old with stage 3-5 CKD who had never undergone dialysis in the nephrology department and the internal medicine department of our hospital between October 2017 to September 2018 were enrolled.Patients were divided into the non-frail group and the frail group according to the Fried frailty phenotype.Clinical data and laboratory results were collected and comprehensive geriatric assessment was carried out to evaluate participants' medication, comorbidities, daily living ability, nutritional status, depression, cognitive and physical performance.The relevant factors for frailty were analyzed.Results:A total of 193 elderly patients with stage 3-5 ND-CKD were enrolled, 106 male and 87 female, including 68 outpatients and 125 inpatients, with a median age of 79.00(73.00, 85.00)years.There were 143 frailty patients(74.1%), including 41 outpatients and 102 inpatients, accounting for 60.3% and 81.6% of the eligible outpatients and inpatients respectively.Multivariable Logistic regression analysis showed that CKD stage( OR=9.74, 95% CI: 1.12-84.54)and polypharmacy( OR=3.69, 95% CI: 1.09-12.42)were associated with frailty in outpatients, and CKD stage( OR=11.75, 95% CI: 1.38-99.99)and malnourishment or risk of malnutrition( OR=4.22, 95% CI: 1.40-12.74)were correlated with frailty in inpatients. Conclusions:The prevalence of frailty is high in elderly patients with stage 3-5 ND-CKD.CKD stage, polypharmacy and malnourishment or the risk of malnutrition are closely correlated with frailty.

With the population aging, the prevalence of chronic kidney disease(CKD)is increasing.Frailty is a complex syndrome in the elderly.Elderly CKD patients have higher risks of frailty and cognitive impairment than the general elderly population.In recent years, the relationship between frailty and cognition has gradually attracted the attention of researchers at home and abroad.Cognitive frailty is regarded as a subtype of frailty and has become one of the research hotspots in the field of gerontology.However, there are few studies on the relationship between CKD and cognitive frailty in the elderly.This article reviews research progress on the topic, including the epidemiology, evaluation methods and possible pathogenesis of cognitive frailty in elderly CKD patients.

The management of frailty in elderly patients with chronic kidney disease (CKD) has been receiving increasing attention.Frailty in elderly patients with CKD has a high incidence and is used for risk prediction of adverse outcomes,including death,hospitalization,falls,dialysis and so on.A range of pathophysiological changes caused by CKD,aging and multimorbidity work together to promote the development of frailty.Treatment for CKD patients with frailty includes mainly nutritional support,exercise,drug therapy and comprehensive intervention.This article reviews recent research progress concerning frailty in elderly CKD patients.

Objective To analyze the frail status and influencing factors of inpatients in geriatrics department.Methods A total of 170 patients aged ≥ 65 years in Geriatrics Department in our hospital were selected.Frailty was defined according to the Clinical Frailty Scale (CFS),and patients were divided into non-frail group and frail group.The differences in comorbidity,physical function,nutrition,cognitive,psychological,geriatrics syndromes,medication,social support and other aspects were analyzed between the two groups by using Comprehensive Geriatrics Assessment(CGA),and correlationof the factors with frailty was evaluated.Results There were 83 (49.0％)patients in frail group and 87 (51.0％)in non-frail group.In frail group versus non-frail group,Charlson comorbidity index was(2.7±2.0)vs.(1.9±1.1),and cumulative illness rating scale was(10.8±3.7) vs.(8.0±2.6) (all P＜0.05);mini-nutrition assessment was(11.2±2.3)vs.(13.0±1.3),and simple cognitive score was(2.7±1.3)vs.(4.1±0.9)(all P＜0.05).Grip,five chair rising,timed get-up and go test,walking speed,SPPB showed statistically significant differences (all P＜ 0.05) between frail group and non-frail group:(20.7±6.6)kg vs.(27.96.7)kg,(30.4±17.5)vs.(12.9±4.1),(23.7± 9.9)vs.(11.7± 3.3),(0.5 ± 0.2)m/s vs.(0.9± 0.2)m/s,(5.6 ± 2.3) vs.(10.3±1.8)respectively.The incidences of incontinence,visual impairment,hearing impairment,sleeping disorder,oral problems,chronic pain,anxiety or depression and fall history were higher in frail patients than in non-frail patients.Living alone,the widowed,nursing staff employment proportion were higher in frail group than in non-frail group.Level of education was lower in frail group than non-frail group.Logistic regression analysis showed that BMI,the walking speed and the number of geriatrics syndromes had a significant impact on frailty(OR=0.789,0.000,2.745,all P＜0.05).Conclusions Incidence rate of frailty in elderly hospitalized patients is high.To identify frailty of hospitalized patients,comprehensive geriatric assessment can be used for understanding frail characteristics and its influencing factors for hospitalized old patients,so as to provide evidence for the reasonable treatment programs.